These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207 [TBL] [Abstract][Full Text] [Related]
6. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma. Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535 [TBL] [Abstract][Full Text] [Related]
7. Expression of nicotinic receptors in normal and tumoral pulmonary neuroendocrine cells (PNEC). Sartelet H; Maouche K; Totobenazara JL; Petit J; Burlet H; Monteau M; Tournier JM; Birembaut P Pathol Res Pract; 2008; 204(12):891-8. PubMed ID: 18667281 [TBL] [Abstract][Full Text] [Related]
8. Kit expression in small cell carcinomas of the lung: effects of chemotherapy. Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988 [TBL] [Abstract][Full Text] [Related]
9. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. Wang DG; Johnston CF; Sloan JM; Buchanan KD J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375 [TBL] [Abstract][Full Text] [Related]
13. The expression of selected neuroendocrine markers and of anti-neoplastic cytokines (IL-2 and IL-12) in lung cancers. Kasprzak A; Przewoźna M; Surdyk-Zasada J; Zabel M Folia Morphol (Warsz); 2003 Nov; 62(4):497-9. PubMed ID: 14655151 [TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma]. Zhao P; Hou N; Shao Y; Li XH Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(22):1526-9. PubMed ID: 16179109 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine neoplasms of the lung: a prognostic spectrum. Asamura H; Kameya T; Matsuno Y; Noguchi M; Tada H; Ishikawa Y; Yokose T; Jiang SX; Inoue T; Nakagawa K; Tajima K; Nagai K J Clin Oncol; 2006 Jan; 24(1):70-6. PubMed ID: 16382115 [TBL] [Abstract][Full Text] [Related]
16. The significance of frequent and independent p53 and bcl-2 expression in large-cell neuroendocrine carcinomas of the lung. Jiang SX; Kameya T; Shinada J; Yoshimura H Mod Pathol; 1999 Apr; 12(4):362-9. PubMed ID: 10229500 [TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. Swarts DR; Ramaekers FC; Speel EJ Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738 [TBL] [Abstract][Full Text] [Related]
18. Specific pattern of LKB1 and phospho-acetyl-CoA carboxylase protein immunostaining in human normal tissues and lung carcinomas. Conde E; Suarez-Gauthier A; García-García E; Lopez-Rios F; Lopez-Encuentra A; García-Lujan R; Morente M; Sanchez-Verde L; Sanchez-Cespedes M Hum Pathol; 2007 Sep; 38(9):1351-60. PubMed ID: 17521700 [TBL] [Abstract][Full Text] [Related]
19. Cellular expression of interleukin 2 (IL-2) and its receptor (IL-2R, CD25) in lung tumours. Kasprzak A; Olejniczak K; Przybyszewska W; Zabel M Folia Morphol (Warsz); 2007 Aug; 66(3):159-66. PubMed ID: 17985312 [TBL] [Abstract][Full Text] [Related]
20. Paucity of beta 2-microglobulin expression on small cell lung cancer, bronchial carcinoids and certain other neuroendocrine tumors. Funa K; Gazdar AF; Minna JD; Linnoila RI Lab Invest; 1986 Aug; 55(2):186-93. PubMed ID: 3525983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]